Why secodary dengue infection more virulent?

  • Thread starter Thread starter sameeralord
  • Start date Start date
  • Tags Tags
    Infection
Click For Summary
SUMMARY

Secondary dengue infections with different serotypes lead to more severe disease due to antibody-mediated enhancement and cytokine storms. When a person is infected with one serotype, they develop immunity to that specific strain but not to others. Upon reinfection with a different serotype, pre-existing antibodies can facilitate viral entry into cells, exacerbating the infection. This phenomenon highlights the complexity of dengue pathology and the challenges in developing effective vaccines.

PREREQUISITES
  • Understanding of dengue virus serotypes and their immune responses
  • Knowledge of cytokine release and its role in viral infections
  • Familiarity with antibody-mediated enhancement mechanisms
  • Basic concepts of viral pathogenesis and immune system interactions
NEXT STEPS
  • Research the mechanisms of antibody-mediated enhancement in viral infections
  • Study the role of cytokines in dengue pathology and other viral diseases
  • Explore current vaccine development efforts for dengue and their challenges
  • Investigate the similarities between dengue and HIV in terms of immune response and infection enhancement
USEFUL FOR

Immunologists, virologists, public health professionals, and anyone involved in dengue research or vaccine development will benefit from this discussion.

sameeralord
Messages
659
Reaction score
3
If u get infected with X serotype of dengue. And then you get infected again with Y serotype you get a severe infection. What is the exact pathology behind this. Also what happens if you get infected by X serotype again, do you get severe infection then as well. Thanks :smile:
 
Biology news on Phys.org
Its thought the reason that reinfection with other serotypes of dengue is so bad is due to more massive cytokine release on the part of the host (humans in this case, I'm not sure how the monkeys that get dengue react to reinfections). So the DIC and other complications are mediated by a cytokine-stormish scenario.

After infection from one dengue serotype, supposing you don't get hemorrhagic fever and die, you should have immunity to that specific serotype--however it does not confer immunity to other serotypes and as mentioned above makes subsequent infections worse.
 
Thanks bobze :smile:
 
To add to the last post, the reason why subsequent infections with different serotypes can be much worse is due to the phenomenon of antibody-mediated enhancement.

As was already said, infection with one serotype will result in the production of antibodies that neutralize that specific serotype. If the same person then becomes infected with a different serotype, those antibodies will then bind to, but not neutralize the new virus. This antibody "coat" on the new virus actually allows it to more easily enter and infect new cells by interacting with antibody Fc receptors.
 
I think that the same goes for HIV, right? The enhancement of infection of the MT 2T-cell, specifically. I think there is some debate going about the sub-neutralizing effects of the vaccine given to volunteers in a study which might lead to a better immune response to HIV. This page here lists many of the antibodies used for these studies. I find it very useful. I personally find it very interesting how companies do progress in this field, but there is still much to be done to develop an effective vaccine.
 

Similar threads

  • · Replies 2 ·
Replies
2
Views
1K
  • · Replies 19 ·
Replies
19
Views
3K
  • · Replies 100 ·
4
Replies
100
Views
10K
Replies
3
Views
2K
  • · Replies 0 ·
Replies
0
Views
708
Replies
5
Views
2K
Replies
1
Views
2K
Replies
3
Views
6K
Replies
1
Views
2K
  • · Replies 3 ·
Replies
3
Views
2K